Viewing Study NCT03208803

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:46 PM
Ignite Modification Date: 2026-05-25 @ 2:43 PM
Study NCT ID: NCT03208803
Status: COMPLETED
Last Update Posted: 2022-07-20
First Post: 2017-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Combination of JAK2 Inhibitor and Erythropoiesis-stimulating Agent in Myelofibrosis
Sponsor: Centre Hospitalier Annecy Genevois
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelofibrosis; Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelofibrosis View
None Erythropoiesis-stimulating Agents View
None Janus Kinase 2 inhibitors View
None Ruxolitinib View